A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir
Influenza and Other Respiratory Viruses · 2026
DOI: 10.1111/irv.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2026. Verfasst von Saira Hussain und 14 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute f…. Hauptthemen laut MEDLINE: Influenza A Virus, H3N2 Subtype, Triazines, Antiviral Agents, Dibenzothiepins. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Government Department of Health, Disability and Ageing, Japanese Ministry of Health, Labor, and Welfare, JSPS KAKENHI.
Abstract (Originalsprache)
The emergence of viruses with reduced susceptibility to antivirals poses an ongoing risk which could limit their effectiveness. Here we report a cluster of A(H3N2) viruses detected in Tasmania, Australia, with a PA gene mutation A37T that showed mild reductions in susceptibility in vitro to baloxavir (3.47‐ to 16.33‐fold increased EC 50 ) when compared to wild‐type influenza A(H3N2) viruses. When the PA‐A37T and PA‐I38T substitutions were combined and tested in IRINA assay, eightfold higher inhibition was seen compared to PA‐I38T alone. On‐going monitoring of influenza viruses for reduced susceptibility to antivirals remains an important part of seasonal and zoonotic influenza surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- Bioinformatics Institute Agency for Science, Technology and Research (A*STAR), Singapore.
- WHO Collaborating Centre for Reference and Research on Influenza, Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
- Pathology Department, Royal Hobart Hospital, Hobart, Tasmania, Australia.
ORCID-Profile: Saira Hussain, Charmaine Chia, Ashwin Muraleetharan, Xiaomin Dong, Emi Takashita, Clyde Dapat, Jessica E Miller, Heidi Peck, Raphael T C Lee, Sebastian Maurer-Stroh, Ian G Barr
Förderung
- Australian Government Department of Health, Disability and Ageing
- Japanese Ministry of Health, Labor, and Welfare
- JSPS KAKENHI
- Department of Health and Aged Care, Australian Government
Zitieren
APA
Hussain, S., Chia, C., Muraleetharan, A., Deng, Y. M., Dong, X., Chanthalavanh, P., Takashita, E., Dapat, C., Miller, J. E., Peck, H., Lee, R. T. C., Williamson, J., Cooley, L., Maurer-Stroh, S., & Barr, I. G. (2026). A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70312
Vancouver
Hussain S, Chia C, Muraleetharan A, Deng YM, Dong X, Chanthalavanh P, et al. A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir. Influenza and Other Respiratory Viruses. 2026. doi:10.1111/irv.70312
BibTeX
@article{Hussain2026,
author = {Hussain, Saira and Chia, Charmaine and Muraleetharan, Ashwin and Deng, Yi-Mo and Dong, Xiaomin and Chanthalavanh, Presa and Takashita, Emi and Dapat, Clyde and Miller, Jessica E and Peck, Heidi and Lee, Raphael T C and Williamson, Jan and Cooley, Louise and Maurer-Stroh, Sebastian and Barr, Ian G},
title = {A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir},
journal = {Influenza and Other Respiratory Viruses},
year = {2026},
doi = {10.1111/irv.70312}
}
EUVIMED